Dashboard Tools Market News Investing Ideas Pricing About Us
Sign Up
Log in
Vita Life Sciences Ltd banner

Vita Life Sciences Ltd
ASX:VLS

Watchlist Manager
Vita Life Sciences Ltd Logo
Vita Life Sciences Ltd
ASX:VLS
Watchlist
Price: 2.6 AUD -3.7% Market Closed
Market Cap: AU$142.1m
Write Note Create Alert Ask AI
Financials Section:
Income Statement Balance Sheet Cash Flow Statement

Balance Sheet

Assets
+
3Y
+51%
5Y
+97%
10Y
+138%
Liabilities
+
3Y
+42%
5Y
+52%
10Y
+133%
Equity
+
3Y
+55%
5Y
+125%
10Y
+140%

Balance Sheet Decomposition
Vita Life Sciences Ltd

Balance Sheet
Vita Life Sciences Ltd

Rotate your device to view
Balance Sheet
Currency: AUD
Dec-2001 Dec-2002 Dec-2003 Dec-2004 Dec-2005 Dec-2006 Dec-2007 Dec-2008 Dec-2009 Dec-2010 Dec-2011 Dec-2012 Dec-2013 Dec-2014 Dec-2015 Dec-2016 Dec-2017 Dec-2018 Dec-2019 Dec-2020 Dec-2021 Dec-2022 Dec-2023 Dec-2024
Assets
Cash & Cash Equivalents
1
2
1
1
1
2
0
1
1
0
2
4
6
7
8
8
6
11
8
10
10
12
5
7
Cash
1
2
1
1
1
2
0
1
1
0
2
4
6
7
8
8
6
0
8
10
10
12
5
7
Cash Equivalents
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
11
0
0
0
0
0
0
Short-Term Investments
0
0
0
0
0
0
0
0
0
0
1
1
3
2
2
2
4
0
2
4
6
4
19
21
Total Receivables
42
4
2
3
4
5
2
2
3
8
3
4
5
0
0
6
7
7
8
7
7
9
11
12
Accounts Receivables
38
3
2
3
3
1
1
2
2
2
3
3
4
0
0
5
6
7
7
6
7
9
11
12
Other Receivables
3
1
0
0
1
4
1
0
1
6
1
1
1
0
0
1
1
0
1
0
0
0
1
0
Inventory
7
7
6
4
3
2
2
3
3
3
4
6
6
0
0
5
5
6
7
7
11
15
11
17
Other Current Assets
0
0
1
1
1
4
0
0
0
0
0
0
1
0
0
1
1
1
1
1
1
1
1
2
Total Current Assets
49
13
10
10
8
13
5
6
7
12
11
16
20
0
0
22
22
25
26
29
35
41
48
59
PP&E Net
3
3
2
2
1
0
0
0
0
0
0
0
0
0
0
9
9
9
9
8
8
8
9
10
PP&E Gross
3
3
2
2
1
0
0
0
0
0
0
0
0
0
0
9
9
0
9
8
8
8
9
10
Accumulated Depreciation
2
2
2
2
2
1
1
2
2
2
2
2
2
2
2
1
2
0
3
3
3
3
3
3
Intangible Assets
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
Goodwill
11
8
8
7
6
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
Note Receivable
0
0
0
0
0
0
1
1
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
Long-Term Investments
0
0
0
0
0
0
0
1
1
2
2
1
1
0
1
1
1
1
0
0
0
0
0
0
Other Long-Term Assets
2
5
0
0
0
0
1
0
0
0
0
0
0
0
0
0
0
1
2
2
2
2
2
3
Other Assets
11
8
8
7
6
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
Total Assets
66
N/A
29
-56%
20
-32%
19
-3%
16
-16%
13
-19%
7
-48%
9
+28%
9
+2%
15
+65%
13
-8%
17
+26%
22
+31%
0
N/A
0
N/A
32
N/A
33
+2%
36
+8%
37
+2%
39
+7%
45
+16%
52
+14%
60
+15%
72
+20%
Liabilities
Accounts Payable
12
8
9
8
7
6
3
3
3
4
4
5
4
2
3
4
4
5
5
6
8
9
10
11
Accrued Liabilities
0
0
0
0
0
0
0
0
0
0
0
0
0
0
1
0
1
1
0
0
0
0
0
0
Short-Term Debt
2
2
1
1
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
Current Portion of Long-Term Debt
0
2
0
1
3
8
1
1
1
2
0
0
0
0
0
0
0
0
1
1
0
0
0
0
Other Current Liabilities
10
2
1
1
1
0
0
0
0
0
1
1
2
0
0
3
1
5
6
6
7
6
6
8
Total Current Liabilities
25
13
12
12
11
15
4
5
5
6
4
5
6
2
4
7
6
11
12
13
14
15
16
19
Long-Term Debt
1
6
17
17
18
0
0
0
0
0
0
0
0
0
0
2
2
2
2
1
0
0
0
0
Deferred Income Tax
0
1
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
Minority Interest
0
0
0
0
0
0
0
1
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
Other Liabilities
1
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
Total Liabilities
26
N/A
20
-24%
29
+46%
29
+1%
30
+2%
15
-49%
4
-75%
5
+41%
5
0%
7
+27%
5
-29%
6
+14%
6
+5%
0
N/A
0
N/A
9
N/A
8
-11%
13
+63%
14
+4%
14
+3%
15
+1%
15
+5%
16
+8%
20
+19%
Equity
Common Stock
38
38
38
38
38
39
44
45
46
46
46
46
46
0
0
45
44
44
42
42
42
42
43
45
Retained Earnings
2
29
47
48
52
40
40
40
41
36
35
33
29
0
0
20
18
22
20
16
11
6
1
5
Unrealized Security Profit/Loss
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
1
1
Other Equity
0
0
0
0
0
1
1
1
2
2
2
2
1
0
0
2
1
0
0
1
1
0
1
2
Total Equity
40
N/A
9
-77%
9
N/A
10
-9%
14
-35%
2
+84%
3
N/A
3
+12%
3
+6%
8
+124%
8
+11%
11
+33%
16
+44%
0
N/A
0
N/A
23
N/A
25
+7%
22
-10%
23
+1%
25
+9%
31
+24%
37
+19%
43
+19%
52
+21%
Total Liabilities & Equity
66
N/A
29
-56%
20
-32%
19
-3%
16
-16%
13
-19%
7
-48%
9
+28%
9
+2%
15
+65%
13
-8%
17
+26%
22
+31%
0
N/A
0
N/A
32
N/A
33
+2%
36
+8%
37
+2%
39
+7%
45
+16%
52
+14%
60
+15%
72
+20%
Shares Outstanding
Common Shares Outstanding
13
13
13
13
12
13
47
49
54
54
58
56
56
0
0
56
57
55
56
54
55
57
56
57

See Also

Summary
VLS intrinsic value, competitors valuation, and company profile.
DCF Valuation
VLS stock valuation using Discount Cash Flow valuation method.
Relative Valuation
VLS stock valuation using valuation multiples.
Wall Street Estimates
VLS price targets and financial estimates made by Wall st analysts.
Profitability Analysis
Detailed analysis of the company's profitability.
Solvency Analysis
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
VLS stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall Street Estimates
Profitability Analysis
Solvency Analysis
Financials
Discount Rate
Discover More
ALPHA SPREAD
Follow us
Join more than 316,400+ value investors using Alpha Spread
Create Free Account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks Wide Economic Moat Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2026 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.